| Info |
| Products |
| IZ worldwide |
| Development |
| Contact |
|
|
| CROATIAN |
|
P.O. Box 266 Head Office: Tel: E-mail: ured@imz.hr |
INSTITUTE OF IMMUNOLOGY INC. is dedicated
to production of medicaments, pharmaceutical products and research/development.
History of the Institute begins in 1893. when Royal institute
for the production of animal small-pox vaccine was found
in Zagreb. In 1961. Institute was named Institute of Immunology.
In 1993. Institute becomes stock company. Today Institute of
Immunology is Croatian largest producer of plasma products,
viral and bacterial vaccines, alergens, antisera etc.
Majority of capacities are situated in Rockefeller Street in Zagreb. Some facilities are in Sveta Nedjelja (20 km from city centre). Until 2010. we expect that all capacities will be moved in Sveta Nedjelja in the new GMP facilities. Construction of new facilities will start in 2007. Here you will find some basic information about history of Institute of Immunology, ownership, financial highlights, human resources, organizational structure and strategic guidelines for development of the Institute.
|
|||||
|
|||||
| |
Institute
of Immunology, Inc., Zagreb has over a century old tradition in
the production of immunobiological substances. The production
started with the Small-Pox Vaccine in Zagreb at the institute
founded by the Croatian Government in 1893. From this beginning
production of an ever-increasing range of bacterial vaccines and
animal sera followed. |
||||
| The broadening of knowledge on the prevention and curing off
infectious diseases imposed new requirements on the production
of immunobiologicals substances. Consequently, the Serovaccinal
Institute, today known as the Institute of Immunology, was established
in 1956 to continue and extend the production of sera and vaccines.
The Institute's goals today are the continuous improvement of
existing products and the creation of new ones.
|
|||||
|
|||||
|
Institute of Immunology
Inc.- is a joint-stock company. Shares are listed at the
Zagreb Stock Exchange. (IMZV-R-A). Main shareholders are
Croatian Privatisation Fund, Croatian Institute for Health Insurance,
Croatian Institute for Pension Insurance and private shreholders.
|
|||
 |
|||
* Croatian Privatisation Fund, Croatian Institute for Health Insurance, Croatian Institute for Pension Insurance
|
|||
|
|||
Institute of Immunology periodically list its financial reports on the Zagreb stock exchange. Please find financial reports as well as some other financial highlights at Zagreb Stock Exchange (in Croatian only).
|
|||
|
||||
| As per February
28 , 2006 Institute of Immunology, Inc. has 348 employees, 87 having
a university degree (20 hold a masters degree and 17 a PhD degree).
The activity of the Institute can be roughly divided into: production
and services and research and development (including teaching).
|
||||
|
||||
|
||||
The structure of the Institute has not substantially modified
over the past decades, and is continuously based on the activities
of particular manufacturing units. The activities are performed
through 11 departments headed by the Management
Office that includes Department
of Internal Audit and Control and Department
of Quality Assurance. At the Department of Research and Development, a number of scientists are employed who are engaged in basic and applied research as well as in educational activities at the University of Zagreb. Five long-term research projects supported by the Ministry
of Science and Technology have been conducted at the Institute
of Immunology. - Department of Viral Vaccines - Department of Bacterial Products and Allergens - Department of Transfusiology - Department of Experimental Animals and Antisera - Department of Plasma Processing - Department of Manufacture Preparation and Finalization - Quality Control Department performs supervision of all manufacture steps, from the control of ingredients and materials through the control of final products, for all Institute products, and puts together registration documentation for the Institute products.
|
||||
|
||||
IN CROATIA - according to the decision issued by the Ministry of Health, Institute of Immunology manufactures, imports and distributes vaccines from the compulsory program of vaccination in the Republic of Croatia; and - according to the decision issued by the Ministry of Health, Institute of Immunology is in charge of plasma collection and processing to albumin and immunoglobulin for intravenous administration, and specific immunoglobulins to cover the needs of the Republic of Croatia. ABROAD - Further development of the Institute of Immunology relies on the development and extension of the manufacture of vaccines for domestic and especially export requirements. - Intensive breakthrough on the international market through the development of new products and basic research is necessary. - Until 1998, Institute of Immunology sold its products on the world market via UNICEF and PAHO. The goal is to qualify measles vaccine production for selling through these agencies in 2004. At present, there is the need of product registration on the markets abroad, which is the primary task in this stage of development. Registration of the products is completed in Mexico, Slovenia, Russia, and is under way in India and Korea. In order to realize these goals, recapitalization of the Institute of Immunology is required, whereby the following preconditions have been met: - a decision has been issued by the respective Ministry and Croatian Privatization Fund, stating that the Government retains 25% +1 share to protect the strategic interest of the state, while the rest can be privatized through recapitalization; - feasibility studies for the construction of the plant for the manufacture of viral vaccines and construction of the plant for human plasma processing have been elaborated; and the procedure of strategic partner selection is under way.
|
||||
|
